Chronic respiratory complications in Stevens–Johnson syndrome/toxic epidermal necrolysis

BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) can cause airway mucosal injury, leading to chronic respiratory complications such as bronchiolitis obliterans (BO) and small-airway disease. As SJS/TEN is rare, its chronic respiratory complications are unclear. Standardised diagnostic and management approaches remain to be established. We aimed to characterise chronic respiratory complications associated with SJS/TEN. METHODS: This retrospective single-centre observational study included 22 patients who attended a speciality ophthalmology clinic for ocular sequelae of SJS/TEN and developed respiratory symptoms after SJS/TEN. Data regarding demographics, medical history, symptoms, diagnoses, computed tomography (CT) findings, pulmonary function, and treatments were collected. CT images were evaluated for mosaic attenuation, bronchiectasis, centrilobular nodules, mucus plugs, and cysts. RESULTS: The median ages of the chronic-phase patients at SJS/TEN onset and evaluation were 13.5 and 50.5 years, respectively. Overall, 77% of patients developed respiratory symptoms within 2 months of onset, whereas 95% showed CT abnormalities. Seven cases were classified as clinically diagnosed BO. Five patients showed mosaic attenuation without obstruction, which suggested small-airway disease. These cases accounted for 55% (12/22) of the symptomatic patients evaluated in this study. Inhaled therapy and long-term macrolides were administered to >50% and 27% of patients, respectively. Three patients were listed for lung transplantation. CONCLUSIONS: Among patients referred for respiratory symptoms after SJS/TEN, many developed early respiratory symptoms and showed chronic-phase CT abnormalities. Assessment of new respiratory symptoms in the early phase, referral to a respiratory specialist, and long-term follow-up should be considered, even when initial imaging abnormalities are mild.

Authors

Institutions

Publication Details

Journal
Respiratory Investigation
Published
2026-10-15
DOI
https://doi.org/10.1016/j.resinv.2026.101526
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chronic respiratory complications in Stevens–Johnson syndrome/toxic epidermal necrolysis

Chie Sotozono, Koichi Takayama, Yurie Seto, Tadaaki Yamada et al.
Respiratory Investigation
Drug-Induced Adverse Reactions
article

Chronic respiratory complications in Stevens–Johnson syndrome/toxic epidermal necrolysis

Chie Sotozono, Koichi Takayama, Yurie Seto, Tadaaki Yamada, Yoshiko Kaneko, Mayumi Ueta, Ayaka Omura, Haruka Kuno
article en

Abstract

BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) can cause airway mucosal injury, leading to chronic respiratory complications such as bronchiolitis obliterans (BO) and small-airway disease. As SJS/TEN is rare, its chronic respiratory complications are unclear. Standardised diagnostic and management approaches remain to be established. We aimed to characterise chronic respiratory complications associated with SJS/TEN. METHODS: This retrospective single-centre observational study included 22 patients who attended a speciality ophthalmology clinic for ocular sequelae of SJS/TEN and developed respiratory symptoms after SJS/TEN. Data regarding demographics, medical history, symptoms, diagnoses, computed tomography (CT) findings, pulmonary function, and treatments were collected. CT images were evaluated for mosaic attenuation, bronchiectasis, centrilobular nodules, mucus plugs, and cysts. RESULTS: The median ages of the chronic-phase patients at SJS/TEN onset and evaluation were 13.5 and 50.5 years, respectively. Overall, 77% of patients developed respiratory symptoms within 2 months of onset, whereas 95% showed CT abnormalities. Seven cases were classified as clinically diagnosed BO. Five patients showed mosaic attenuation without obstruction, which suggested small-airway disease. These cases accounted for 55% (12/22) of the symptomatic patients evaluated in this study. Inhaled therapy and long-term macrolides were administered to >50% and 27% of patients, respectively. Three patients were listed for lung transplantation. CONCLUSIONS: Among patients referred for respiratory symptoms after SJS/TEN, many developed early respiratory symptoms and showed chronic-phase CT abnormalities. Assessment of new respiratory symptoms in the early phase, referral to a respiratory specialist, and long-term follow-up should be considered, even when initial imaging abnormalities are mild.

Respiratory InvestigationVol. 64(6)
Kyoto Prefectural University of Medicine (JP)
Japan Society for the Promotion of Science London
Good health and well-being
Openalex Percentile: Top 14%
Drug-Induced Adverse Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.